Proportion of isolates with decreased susceptibility or resistance (DS/R) to extended-spectrum cephalosporins reported to WHO-GASP
Filters
Proportion of isolates with decreased susceptibility or resistance (DS/R) to extended-spectrum cephalosporins reported to WHO-GASP
Germany
Proportion of isolates with decreased susceptibility or resistance (DS/R) to extended-spectrum cephalosporins reported to WHO-GASP
20092018
Reported resistance to extended-spectrum cephalosporins by country in 2016 (proportion of isolates with decreased susceptibility or resistance (DS/R) to extended-spectrum cephalosporins reported to WHO-GASP)
In 2016, Myanmar had the highest value (100) among 6 countries.
| # | Country | Value | Change |
|---|---|---|---|
| 1 | Myanmar | 100 | – |
| 1 | Cyprus (2018) | 20 | – |
| 1 | Romania (2011) | 15.38 | – |
| 1 | China (2017) | 11.67 | -3.2% |
| 2 | Malawi | 92.01 | – |
| 2 | Japan (2018) | 19.08 | -10.1% |
Similar Datasets
Number of isolates tested for azithromycin
WHO (GASPTIAZM)
Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP
WHO (GASPRSCRO)
Number of isolates tested for cefixime
WHO (GASPTICFM)
Proportion of isolates with resistance to ciprofloxacin reported to WHO-GASP
WHO (GASPRSCIP)